Picture of Hanmi Pharm Co logo

128940 Hanmi Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Hanmi Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line81,478101,558165,366140,431187,136
Depreciation
Amortisation
Non-Cash Items104,12876,23967,48382,01299,290
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-72,769-112,370-114,766-126,288-212,162
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities201,923162,269216,538193,487173,072
Capital Expenditures-34,425-49,593-43,736-62,554-76,547
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-8,964-131,815-139,73687,405-82,908
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-43,389-181,408-183,47224,851-159,455
Financing Cash Flow Items00.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-113,331-36,867-126,787-93,767-97,190
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash63,067-61,896-92,348137,297-84,004